These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17076596)

  • 1. Influence of protein transduction domains on intracellular delivery of macromolecules.
    Murriel CL; Dowdy SF
    Expert Opin Drug Deliv; 2006 Nov; 3(6):739-46. PubMed ID: 17076596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment.
    Harada H; Kizaka-Kondoh S; Hiraoka M
    Breast Cancer; 2006; 13(1):16-26. PubMed ID: 16518058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cellular function by TAT mediated transduction of full length proteins.
    Wadia JS; Dowdy SF
    Curr Protein Pept Sci; 2003 Apr; 4(2):97-104. PubMed ID: 12678849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
    Morris MC; Depollier J; Mery J; Heitz F; Divita G
    Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular cargo delivery using tat peptide and derivatives.
    Zhao M; Weissleder R
    Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody mediated transduction of therapeutic proteins into living cells.
    Hansen JE; Weisbart RH; Nishimura RN
    ScientificWorldJournal; 2005 Sep; 5():782-8. PubMed ID: 16170440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
    Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
    Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application.
    Zhang X; Zhang X; Wang F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):457-72. PubMed ID: 22432469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
    Bolhassani A; Jafarzade BS; Mardani G
    Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
    Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
    J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological applications of protein transduction technology.
    Kabouridis PS
    Trends Biotechnol; 2003 Nov; 21(11):498-503. PubMed ID: 14573363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
    Kaplan IM; Wadia JS; Dowdy SF
    J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The taming of the cell penetrating domain of the HIV Tat: myths and realities.
    Chauhan A; Tikoo A; Kapur AK; Singh M
    J Control Release; 2007 Feb; 117(2):148-62. PubMed ID: 17196289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.
    Al-Taei S; Penning NA; Simpson JC; Futaki S; Takeuchi T; Nakase I; Jones AT
    Bioconjug Chem; 2006; 17(1):90-100. PubMed ID: 16417256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAT-based drug delivery system--new directions in protein delivery for new hopes?
    Rapoport M; Lorberboum-Galski H
    Expert Opin Drug Deliv; 2009 May; 6(5):453-63. PubMed ID: 19413454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein transduction domain delivery of therapeutic macromolecules.
    van den Berg A; Dowdy SF
    Curr Opin Biotechnol; 2011 Dec; 22(6):888-93. PubMed ID: 21489777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.